Overview
- 5 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-09-26.
At a glance
Inspections
5
Form 483s
5
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 18 Sep 2025 – 26 Sep 2025 | Human Drugs | 483 | On file |
| 12 Aug 2024 – 20 Aug 2024 | Human Drugs | 483 | View 483 → |
| 14 Nov 2023 – 20 Nov 2023 | Human Drugs | 483 | View 483 → |
| 29 Nov 2022 – 6 Dec 2022 | Human Drugs | 483 | On file |
| 13 Jan 2022 – 22 Jan 2022 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
20 Aug 2024
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Gavin T Cua, Crystal Monroy
20 Aug 2024
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Gavin T Cua, Crystal Monroy
20 Aug 2024
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Gavin T Cua, Crystal Monroy
20 Nov 2023
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Kellia N Hicks
Investigators
FDA investigators tied to this site in the record.
Chad W Rice1 insp.
Sandra A Boyd1 insp.
Hung H Do1 insp.
Gavin T Cua1 insp.
Crystal Monroy1 insp.
Kellia N Hicks1 insp.
Marcellinus D Dordunoo1 insp.
Rita K Kabaso1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(v) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(vi) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.46(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.94(c) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Abryl Laboratories Private Limited's 5 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat